Wasko-Czopnik D, Wiatrak B. The efficacy and safety of itopride as an add-on
therapy to a proton pump inhibitor in the treatment
of gastroesophageal reflux disease. Gastroenterology Review/Przegląd Gastroenterologiczny. 2024;19(1):60-66. doi:10.5114/pg.2023.133915.
APA
Wasko-Czopnik, D., & Wiatrak, B. (2024). The efficacy and safety of itopride as an add-on
therapy to a proton pump inhibitor in the treatment
of gastroesophageal reflux disease. Gastroenterology Review/Przegląd Gastroenterologiczny, 19(1), 60-66. https://doi.org/10.5114/pg.2023.133915
Chicago
Wasko-Czopnik, Dorota, and Benita Wiatrak. 2024. "The efficacy and safety of itopride as an add-on
therapy to a proton pump inhibitor in the treatment
of gastroesophageal reflux disease". Gastroenterology Review/Przegląd Gastroenterologiczny 19 (1): 60-66. doi:10.5114/pg.2023.133915.
Harvard
Wasko-Czopnik, D., and Wiatrak, B. (2024). The efficacy and safety of itopride as an add-on
therapy to a proton pump inhibitor in the treatment
of gastroesophageal reflux disease. Gastroenterology Review/Przegląd Gastroenterologiczny, 19(1), pp.60-66. https://doi.org/10.5114/pg.2023.133915
MLA
Wasko-Czopnik, Dorota et al. "The efficacy and safety of itopride as an add-on
therapy to a proton pump inhibitor in the treatment
of gastroesophageal reflux disease." Gastroenterology Review/Przegląd Gastroenterologiczny, vol. 19, no. 1, 2024, pp. 60-66. doi:10.5114/pg.2023.133915.
Vancouver
Wasko-Czopnik D, Wiatrak B. The efficacy and safety of itopride as an add-on
therapy to a proton pump inhibitor in the treatment
of gastroesophageal reflux disease. Gastroenterology Review/Przegląd Gastroenterologiczny. 2024;19(1):60-66. doi:10.5114/pg.2023.133915.
